Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Usana Health Sciences's Enterprise Value is $426.6 Mil.
Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $76.6 Mil. Therefore, Usana Health Sciences's EV-to-EBIT ratio for today is 5.57.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Usana Health Sciences's Enterprise Value is $426.6 Mil.
Usana Health Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $98.9 Mil. Therefore, Usana Health Sciences's EV-to-EBITDA ratio for today is 4.32.
Usana Health Sciences Enterprise Value Historical Data
The historical data trend for Usana Health Sciences's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Usana Health Sciences's Enterprise Value
For the Packaged Foods subindustry, Usana Health Sciences's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences's Enterprise Value Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Enterprise Value falls into.
Usana Health Sciences Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Usana Health Sciences's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (NYSE:USNA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Usana Health Sciences's current Enterprise Value is $426.6 Mil.
Usana Health Sciences's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $76.6 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Usana Health Sciences's EV-to-EBITDA for today is:
Usana Health Sciences's current Enterprise Value is $426.6 Mil.
Usana Health Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $98.9 Mil.
Usana Health Sciences's current Enterprise Value is $426.6 Mil.
Usana Health Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $854.5 Mil.
Usana Health Sciences's current Enterprise Value is $426.6 Mil.
Usana Health Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $50.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences Enterprise Value Related Terms
Thank you for viewing the detailed overview of Usana Health Sciences's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
USNA has been successfully added to your 